In the absence of antigenic or mitogenic stimulation, certain peripheral blood lymphocytes exhibit proliferative and lymphokine-activated killer (LAK) cell activities when cultured with recombinant IL-2. Both activities were found to be an exclusive property of lymphocytes expressing type 3 complement receptors (CR3) identified by anti-CD1 1 monoclonal antibodies. CD11+ lymphocytes were then fractionated into three subsets by two-color flow cytometry. These included CD16+ cells, which display distinctive Fc receptors for IgG (CD16). Using anti-CD5, the CD11+ CD16-lymphocytes were separated into non-T cell and T cell subsets. The two non-T cell subsets (CD11+ CD16+ and CD11+ CD16-CD5-), but not the T cell subset (CD11+ CD16-CD5+), could proliferate in response to IL-2. Both CD11+ non-T cell subsets, but not the CD11+ T cell subset, had the capacity to mediate natural killer cell activity. However, all three CD1 1 + lymphocyte subsets were capable of generating LAK activity. These findings are consistent with the concept that two signals are required to stimulate T cells to proliferate. However, at least a small subset of blood T cells can be activated by IL-2 to become LAK cells.
Introduction
IL-2 is a T cell-derived lymphokine that is the principal growth factor for T cells (1, 2) . It has been postulated that IL-2 acts upon T cells that have received a first signal provided by antigen or mitogen, but not upon resting T cells (3) (4) (5) . However, in the absence of a first signal, "resting" peripheral blood T cells have been reported to proliferate in response to IL-2 (6-1 1). Natural killer (NK)' cells can proliferate in response to IL-2 (8, 11, 12 ), but if T cells also have this capacity, this finding would conflict with the two-signal theory of T cell activation.
Lymphocytes mediating cytotoxic activity after culture with IL-2 have been called lymphokine-activated killer cells (LAK) (13) . This cytotoxicity is non-MHC restricted and the Received for publication 27 April 1987 and in revisedform 2 October 1987.
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IL-2R, IL-2 receptor; LAK, lymphokine-activated killer cell; NK, natural killer; rIL-2, recombinant IL-2; UNF, unfractionated PBMC. target cells killed include those that are resistant to NK cells (13) . The precursors of LAK activity are less well defined. Although LAK activity can be derived from NK cells (11) , lymphocyte populations devoid of or depleted of NK activity also demonstrate LAK activity upon culture in the presence of IL-2 (14, 15) .
In the present study, we have characterized the phenotype of lymphocytes which proliferate in response to IL-2 and which are the precursors of LAK cells. PBMC were separated using anti-CD11 monoclonal antibodies that react with receptors for the iC3b component of complement (16, 17) . These receptors have been called type 3 complement receptors (CR3) (18) . Activities associated with the lymphocyte populations identified by anti-CD11 monoclonal antibodies include NK cell activity (19, 20) , antibody-dependent cellular cytotoxic activity ( 19) , and the suppression of IgG production induced by pokeweed mitogen (21) . We report that all IL-2 responsiveness was contained exclusively within the CD11 + lymphocyte populations.
Methods
PBMC. Peripheral blood, obtained from healthy volunteers by venipuncture, was separated by Ficoll-Hypaque (Isolymph; Gallard-Schlesinger Corp., Carle Place, NY) density centrifugation. Mononuclear cells were then washed three times and resuspended in RPMI 1640 medium (Irvine Scientific, Santa Ana, CA) containing glutamine (2 mM), gentamicin (20 ,g/ml), and Hepes buffer (10 mM) , and supplemented with 10% human AB serum (Irvine Scientific).
Monoclonal antibodies. The monoclonal antibodies used in this study were anti-CD Although monocytes also react with anti-CD 11, they can be distinguished from lymphocytes by the intensity of fluorescence staining (22) in addition to light scatter characteristics. Peroxidase staining ofsorted CD 11+ lymphocytes, as a further check for monocytes, revealed that all populations were < 5% positive.
Lymphocyte subsets that proliferate in response to IL-2. In preliminary experiments, PBMC were incubated with 10-10,000 U/ml of IL-2 for 3 d. The proliferative response observed with 100 U/ml was at least 80% of the maximal response observed at higher concentrations, and 100 U/ml was selected for further studies unless stated otherwise.
Consistent with the observations of others (6-1 1), PBMC cultured for 3 d in the presence of rIL-2, in the absence of any other mitogenic or antigenic stimulus, exhibit proliferative activity (Table II) .
To define the lymphocyte population(s) mediating this proliferative activity, lymphocytes were sorted into CD 1 + and CD 11-populations using anti-CD11 monoclonal antibodies. Lymphocytes stained with anti-CD1I1 did not proliferate in the absence of IL-2 and virtually identical proliferative activity was observed between PBMC and PBMC stained with the anti-CD11 monoclonal antibodies (data not shown). Therefore, the anti-CD1 1 monoclonal antibody itselfis not an activation signal. In the three experiments shown in Table II , proliferation in response to IL-2 was detectable only in the CD 1 + population. This experiment was repeated with cells from seven other donors, and in only one case was proliferative activity detected in the CDl 1-population. The PBMC from the latter donor were used to determine whether the IL-2 receptor recognized by anti-TAC was required for proliferative activity. CD1 1 + and CDl 1-cell fractions from this donor were then stained with anti-IL-2 receptor (IL-2R), and the IL-2R-positive cells were removed by cell sorting. This procedure markedly reduced the proliferative activity of CD 11-lymphocytes, but had no significant effect on CDl 1 + cells (Table III) .
The unresponsiveness of the CD 11-lymphocytes was not simply due to a lack of accessory cells. The addition of adherent cells, highly enriched for monocytes, did not result in any proliferative response to IL-2 by the CD 11-lymphocytes (Table IV) . In this experiment the CD 11+ lymphocytes exhibited a highly augmented proliferative activity compared with the activity of unfractionated PBMC. In six experiments, either IL-2 or PHA was added to CD 11-cells: in each case the CD1 1-cells did not proliferate in response to IL-2, but the expected response to PHA was observed (results not shown).
Lymphocytes expressing CR3 are phenotypically heterogeneous and co-express surface determinants associated with T cells or NK cells (22) (23) (24) . Approximately 60% of CDl 1 + lym- phocytes also express Fc receptors for IgG, which are detectable by anti-CD 16 monoclonal antibodies that define a population of lymphocytes highly enriched in NK activity (25) (26) (27) .
To determine whether the IL-2-induced proliferative activity was mediated by NK-associated CDl 1 + lymphocytes, PBMC were sorted to provide populations of CD 11 + CD 16+, CDl 1+ CD16-, and CD1 1-(CD 16-) lymphocytes. Both CD 16+ and CD 16-subsets of CDl 1 + lymphocytes demonstrated proliferative activity upon culture in the presence of IL-2 (Fig. 1) . As already noted CDl 1-lymphocytes did not respond to IL-2. It was possible that the difference in proliferative activity of the lymphocyte populations varied depending on the kinetics ofresponses to IL-2. To test this, sorted populations ofCD 11+ CD16+, CD1 1+ CD16-, and CD 11-lymphocytes were cultured in the presence of rIL-2 and assessed for proliferative activity at various times. The proliferative activity of the IL-2-responsive populations (CDl1+ CD16-, CDll+ CD 16+) was greater at day 6 than at day 3 (Table V) . With one exception, proliferation of the CD11 + CD16-subset was greater than that observed with unfractionated or CD 11+ CD 16+ lymphocytes. At day 6 there was small, but significant proliferative activity of the CD 11-cells.
Approximately 18% of CD 11+ lymphocytes co-express pan T markers recognized by anti-CD5 or anti-CD3 monoclonal antibodies (22) . With rare exceptions, CD5 and CD3 are expressed exclusively in the CD 16-subset (27-29) . To further identify the CDl 1 + IL-2 responsive cells, the CDl 1 + CD16-lymphocytes were further sorted into CD5+ and CD5-fractions. All populations of lymphocytes were then cultured in the presence of rIL-2 and assayed for proliferative activity after 3 d of culture. In the experiment shown in Fig. 2 , proliferative activity was only detected in the CD5-subset, although this was always lower than that of the CDl 1 + CD16-population. Similar results were observed in two other experiments. In these studies there was no significant proliferative activity detected in the CD5+ subset after 7 d of culture (data not shown).
Cytotoxic activity of IL-2-cultured lymphocytes. In addition to proliferative activity, human PBMC cultured in IL-2 can kill NK-sensitive and NK-resistant target cells. The mediators of this cytotoxic activity have been called LAK cells (13 (Fig. 3) . Both CD 11+ subsets were cytolytic to K562 and RAJ 1, whereas the CD11 -lymphocytes were noncytotoxic. These experiments were repeated four times with similar results. The anti-CD 11 and/or anti-CD 16 monoclonal antibodies did not activate NK cells, since PBM stained with either or both monoclonal antibodies did not have any increased cytotoxic activity in NK or LAK assays as compared with unstained PBMC (data not shown). This finding was consistent with similar studies with anti-CD11 reported previously (19) .
Relationship of IL-2-responsive lymphocytes to NK cells. As lymphocytes reactive with anti-CD 16 monoclonal antibodies are associated with NK activity (25, 27) , the results of Fig. 3 were initially interpreted as an IL-2-induced augmentation of NK activity by CDl 1 + CD16+ lymphocytes and the induction by IL-2 of cytotoxic activity in the CDl 1 + CD 16- population. This possibility was tested by assaying the sorted lymphocyte populations for cytolytic activity against K562 before culture (Fig. 4) . Cytotoxic activity was highly enriched in the CD 1 I+ CD16+ lymphocyte fraction. However, the CDl 1 + CD16-fraction also contained lymphocytes that were cytotoxic to K562. These results suggested that cytotoxic activ- ity, after culture in IL-2, results from lymphocyte populations presumably capable of mediating NK activity.
To further define the CD 1I+ CD 16-lymphocytes mediating NK activity, cells were sorted into CD5+ and CD5-subsets and assayed for NK activity (Fig. 5 and Fig. 6 A) . This cytotoxic activity was detectable only in the CD5-fraction of the CDl 1 + CD16-lymphocytes. No cytotoxic activity was found in the CD 11+ CD16-CD5+ or CD 11-populations. No effect on the level of NK activity was observed when PBL stained with anti-CD5 were assayed, indicating that anti-CD5 by itself did not result in any modulation of NK activity.
Each of the sorted lymphocyte populations was then assessed for cytotoxic activity against K562 (Fig. 6 B) and RAJ 1 (Fig. 6 C) after culture in the presence of IL-2. All the CD 1 + fractions mediating endogenous NK activity (Fig. 6 A) were also cytotoxic after culture in IL-2 (Fig. 6 B and C) . However, the CD 1I + CD 16-CD5+ subset, which did not have endogenous NK activity, exhibited cytotoxic activity against both K562 and RAJ1 after culture in IL-2. Similar results were obtained in two other experiments. Moreover, when assayed for cytotoxic activity against another NK-resistant cell line, Daudi, the same CD11+ lymphocyte subpopulations mediated LAK cell activity in three separate experiments. One such experiment is shown in Table VI . Thus, after culture with IL-2, all three CD 11 + lymphocyte subpopulations had cytotoxic activity against NK-susceptible and NK-resistant target cells.
Discussion
The lymphocyte populations that respond to IL-2 in shortterm cultures in the absence of any mitogenic or antigenic stimulus have been identified. Whether we assayed responsiveness to IL-2 as proliferative activity or cytotoxic activity, this was an exclusive characteristic of lymphocytes displaying CR3 as detected by anti-CD 11 monoclonal antibodies. Two non-T CD 1I+ lymphocyte subsets responding to IL-2 were identified. These were CD16+ lymphocytes with Fc receptors for IgG (26, 27) , and CD 16-CD5-cells. T cells in the CDl 1-fraction and CD 1I + CD5+ lymphocytes did not proliferate in response to IL-2, a finding consistent with the two-signal concept of T cell activation. After 7 d of culture, there was small but significant proliferative activity by CD 11-lymphocytes, but this finding was possibly associated with the generation of an autologous mixed lymphocyte culture or by activation due to serum components.
While proliferation in the presence of IL-2 was found to be an exclusive property of CD 1 + lymphocytes, this population of lymphocytes are heterogeneous in their expression of other cell surface antigens. Approximately half of the CD 1I+ lymphocytes co-express the CD2 antigen or sheep erythrocyte receptor (23, 24) . Therefore, previous studies demonstrating IL-2-induced proliferative activity in both erythrocyte-positive and erythrocyte-negative fractions would not be unexpected, and probably does not reflect T cell proliferation (6, 7) . As approximately one-third of CD 1 + lymphocytes also express the CD8 antigen, the reported proliferation of both CD8+ and CD8-lymphocytes is again consistent with our findings (9, 1 1). Finally, as only 4-5% of CD 1 + lymphocytes co-express the CD4 antigen (22) , the observation that CD4+ lymphocytes do not proliferate in response to IL-2 is also consistent with our results (6, 1 1). Interestingly, in the present study the proliferative activity of the CD5-subset of CD1 1+ CD16-lymphocytes was always less than that of the unfractionated CDl 1 + CD 16-population. This finding suggests that the CD5+ subset, although demonstrating little or no proliferation in the presence of IL-2, was capable of amplifying the response to IL-2 of the CD5-subset. Itoh et al. also documented the ability of an IL-2-nonresponsive population to augment the proliferation of an IL-2-responsive population (1 1).
In addition to the proliferative activity, LAK activity was an exclusive property of CD1 1+ lymphocytes. Grimm et al. reported previously that LAK activity could develop from CD 11 -precursors (14) , but these conclusions were based upon complement-dependent cytolysis of CDl 1 + cells using OKM 1, a method much less efficient than the flow cytometry procedure used in the present studies. Consistent with our findings, Itoh et al. found that cytotoxic activity after culture in IL-2 was attributable to CD 16+ lymphocytes (11) . However, our studies also revealed that CD 16-(CD 11+) lymphocytes mediate cytotoxic activity after culture in IL-2. The inability of Itoh et al. (11) to detect cytotoxic activity in the CD 16-population was possibly due to the relatively low concentration (10 U) of rIL-2 used. LYMPHOCYTE SUBPOPULATION Figure 5 . PBMC or the indicated purified lymphocyte subpopulations were assayed for cytotoxic activity against K562 in a 4-h 5'Cr release assay at an effector to target ratio of 15:1. Although the CD5+ subset of CR3+ lymphocytes did not proliferate in response to IL-2 or mediate NK activity, this subset did develop LAK activity in the presence of IL-2. This minor T cell subset was the only T cell subset capable of responding to IL-2. These results differ from the observations of Phillips and Lanier, who reported that all the precursors of LAK cells in blood were non-T cells (30) . These workers found that CD5+ Leu 19+ cultured with IL-2 killed NK-susceptible, but not NK-resistant, target cells (30) . Possible explanations of the differences between the observations of Phillips and Lanier (30) and our findings may reflect the target cells used and the time of culture in the presence of IL-2. Phillips and Lanier (30) cultured cells for 7 d, whereas we have found Recently, a 70-kD IL-2 binding protein distinct from the CD25 (Tac) IL-2 receptor has been described which binds IL-2 with an intermediate affinity (33) (34) (35) (36) . It has been reported that natural killer cells (35, 37) and resting T cells (37) can express this 70-kD protein. Our studies would suggest that expression of the 70-kD protein on CD 1 + lymphocytes is sufficient for IL-2 responsiveness, whereas expression of this molecule by itself is insufficient for responsiveness by CDl 1-lymphocytes.
